Guangdong VTR Bio-Tech Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 4.98%

Guangdong VTR Bio-Tech Co Ltd (300381) has an Asset Resilience Ratio of 4.98% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Guangdong VTR Bio-Tech Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥143.28 Million

≈ $20.97 Million USD Cash + Short-term Investments

Total Assets

CN¥2.88 Billion

≈ $421.34 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Guangdong VTR Bio-Tech Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 300381 total assets.

Liquid Assets Composition Over Time

This chart breaks down Guangdong VTR Bio-Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 300381 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥143.28 Million	4.98%
Total Liquid Assets	CN¥143.28 Million	4.98%

Asset Resilience Insights

Limited Liquidity: Guangdong VTR Bio-Tech Co Ltd maintains only 4.98% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guangdong VTR Bio-Tech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangdong VTR Bio-Tech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for Guangdong VTR Bio-Tech Co Ltd (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Guangdong VTR Bio-Tech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	6.79%	CN¥198.72 Million ≈ $29.08 Million	CN¥2.92 Billion ≈ $428.01 Million	-4.47pp
2024-12-31	11.26%	CN¥332.13 Million ≈ $48.60 Million	CN¥2.95 Billion ≈ $431.47 Million	-6.95pp
2023-12-31	18.21%	CN¥563.70 Million ≈ $82.49 Million	CN¥3.09 Billion ≈ $452.89 Million	-3.50pp
2022-12-31	21.72%	CN¥688.89 Million ≈ $100.81 Million	CN¥3.17 Billion ≈ $464.18 Million	+21.56pp
2016-12-31	0.16%	CN¥5.00 Million ≈ $731.66K	CN¥3.21 Billion ≈ $469.70 Million	-12.30pp
2014-12-31	12.46%	CN¥120.04 Million ≈ $17.57 Million	CN¥963.36 Million ≈ $140.97 Million	--

pp = percentage points

About Guangdong VTR Bio-Tech Co Ltd

SHE:300381 China Biotechnology

Market Cap

$398.09 Million

CN¥2.72 Billion CNY

Market Cap Rank

#13547 Global

#4060 in China

Share Price

CN¥5.54

Change (1 day)

-0.36%

52-Week Range

CN¥5.40 - CN¥7.55

All Time High

CN¥34.00